Screen Reader Mode Icon

Question Title

* 1. Last Name:

Question Title

* 2. E-mail Address:

Question Title

* 3. Disclosure of relevant conflicts of interest for individuals in control content was provided in advance of my participation in the accredited education.

Question Title

* 4. Disclosure of whether or not there was commercial support received from ACCME defined commercial interests was provided in advance of my participation in the accredited education:

Question Title

* 5. The learning objectives were actionable and measurable and supported by the activity content:

Question Title

* 6. The activity format was appropriate for the setting and relevant to my practice:

Question Title

* 7. The activity content was fair balanced and free of bias:

Question Title

* 8. Scientific studies cited within the activity conform to standards acceptable by the scientific community:

Question Title

* 9. Are there any issues you would like to raise regarding the activity content?

Question Title

* 10. Will you make changes in your practice because of your participation in the activity?

Question Title

* 11. Prescribers without an FDA x waiver may prescribe buprenophine…

Question Title

* 12. As per national guidelines, parenteral opioids are appropriate first-line treatment for which pain condition?

Question Title

* 13. Which of these guidelines may decrease the risk of developing opioid use disorder?

Question Title

* 14. Which of the following opioids cause the least euphoria?

Question Title

* 15. Recommended duration of opioid prescription is...

Question Title

* 16. The management of ED Pain Management should include the following:

Question Title

* 17. What is the most important way clinicians can reduce the likelihood that opioid-naive patients being discharged with a painful condition will develop long term opioid use/opioid addiction?

Question Title

* 18. Patients with cancer with poor functional status (e.g. confined to a bed or chair for > 50% of their day, capable of limited self-care) have a median survival of:

Question Title

* 19. Ketamine-The Jack of All Trades (Andonian)

  5 (Highest) 4 3 2 1 (Lowest)
Professional value of this session
Presenter’s teaching skills
Quality of the audio-visuals for this session

Question Title

* 20. Ketamine-The Jack of All Trades (Andonian)

  Just Right Too Basic Too Advanced
Level of course content

Question Title

* 21. Ketamine-The Jack of All Trades (Andonian)

  Just Right Too Long Too Short
Amount of time allowed for this session

Question Title

* 22. Ketamine-The Jack of All Trades (Andonian)

  Agree Disagree
Presentation was balanced and free of commercial bias

Question Title

* 23. The Opioid Crisis in Evolution (Cowan)

  5 (Highest) 4 3 2 1 (Lowest)
Professional value of this session
Presenter’s teaching skills
Quality of the audio-visuals for this session

Question Title

* 24. The Opioid Crisis in Evolution (Cowan)

  Just Right Too Basic Too Advanced
Level of course content

Question Title

* 25. The Opioid Crisis in Evolution (Cowan)

  Just Right Too Long Too Short
Amount of time allowed for this session

Question Title

* 26. The Opioid Crisis in Evolution (Cowan)

  Agree Disagree
Presentation was balanced and free of commercial bias

Question Title

* 27. Pain Management-An Emergency Medicine Perspective (Friedman)

  5 (Highest) 4 3 2 1 (Lowest)
Professional value of this session
Presenter’s teaching skills
Quality of the audio-visuals for this session

Question Title

* 28. Pain Management-An Emergency Medicine Perspective (Friedman)

  Just Right Too Basic Too Advanced
Level of course content

Question Title

* 29. Pain Management-An Emergency Medicine Perspective (Friedman)

  Just Right Too Long Too Short
Amount of time allowed for this session

Question Title

* 30. Pain Management-An Emergency Medicine Perspective (Friedman)

  Agree Disagree
Presentation was balanced and free of commercial bias

Question Title

* 31. State and Federal Requirements for Prescribing Controlled Substances and Appropriate Prescribing (Majlesi)

  5 (Highest) 4 3 2 1 (Lowest)
Professional value of this session
Presenter’s teaching skills
Quality of the audio-visuals for this session

Question Title

* 32. State and Federal Requirements for Prescribing Controlled Substances and Appropriate Prescribing (Majlesi)

  Just Right Too Basic Too Advanced
Level of course content

Question Title

* 33. State and Federal Requirements for Prescribing Controlled Substances and Appropriate Prescribing (Majlesi)

  Just Right Too Long Too Short
Amount of time allowed for this session

Question Title

* 34. State and Federal Requirements for Prescribing Controlled Substances and Appropriate Prescribing (Majlesi)

  Agree Disagree
Presentation was balanced and free of commercial bias

Question Title

* 35. State and Federal Requirements for Prescribing Controlled Substances-Part II (Majlesi)

  5 (Highest) 4 3 2 1 (Lowest)
Professional value of this session
Presenter’s teaching skills
Quality of the audio-visuals for this session

Question Title

* 36. State and Federal Requirements for Prescribing Controlled Substances-Part II (Majlesi)

  Just Right Too Basic Too Advanced
Level of course content

Question Title

* 37. State and Federal Requirements for Prescribing Controlled Substances-Part II (Majlesi)

  Just Right Too Long Too Short
Amount of time allowed for this session

Question Title

* 38. State and Federal Requirements for Prescribing Controlled Substances-Part II (Majlesi)

  Agree Disagree
Presentation was balanced and free of commercial bias

Question Title

* 39. Practical Approach to Pain Management in Acute Care Setting: Do’s, Don’ts and Some Maybe’s… (Motov)

  5 (Highest) 4 3 2 1 (Lowest)
Professional value of this session
Presenter’s teaching skills
Quality of the audio-visuals for this session

Question Title

* 40. Practical Approach to Pain Management in Acute Care Setting: Do’s, Don’ts and Some Maybe’s… (Motov)

  Just Right Too Basic Too Advanced
Level of course content

Question Title

* 41. Practical Approach to Pain Management in Acute Care Setting: Do’s, Don’ts and Some Maybe’s… (Motov)

  Just Right Too Long Too Short
Amount of time allowed for this session

Question Title

* 42. Practical Approach to Pain Management in Acute Care Setting: Do’s, Don’ts and Some Maybe’s… (Motov)

  Agree Disagree
Presentation was balanced and free of commercial bias

Question Title

* 43. Prevention and Identification of Opioid Use Disorder (Strayer)

  5 (Highest) 4 3 2 1 (Lowest)
Professional value of this session
Presenter’s teaching skills
Quality of the audio-visuals for this session

Question Title

* 44. Prevention and Identification of Opioid Use Disorder (Strayer)

  Just Right Too Basic Too Advanced
Level of course content

Question Title

* 45. Prevention and Identification of Opioid Use Disorder (Strayer)

  Just Right Too Long Too Short
Amount of time allowed for this session

Question Title

* 46. Prevention and Identification of Opioid Use Disorder (Strayer)

  Agree Disagree
Presentation was balanced and free of commercial bias

Question Title

* 47. Palliative Care: What You Need to Know (Tan)

  5 (Highest) 4 3 2 1 (Lowest)
Professional value of this session
Presenter’s teaching skills
Quality of the audio-visuals for this session

Question Title

* 48. Palliative Care: What You Need to Know (Tan)

  Just Right Too Basic Too Advanced
Level of course content

Question Title

* 49. Palliative Care: What You Need to Know (Tan)

  Just Right Too Long Too Short
Amount of time allowed for this session

Question Title

* 50. Palliative Care: What You Need to Know (Tan)

  Agree Disagree
Presentation was balanced and free of commercial bias
0 of 50 answered
 

T